SEC Comment Letter 0000000000-23-010059 to Huaizhong Health Group, Inc. (ADAD) (CIK 0001593204)
Huaizhong Health Group, Inc. (ADAD) (CIK 0001593204)
Date: Sept. 12, 2023 · CIK: 0001593204 · Accession: 0000000000-23-010059
AI Filing Summary & Sentiment
File numbers found in text: 000-55369
Show Raw Text
United States securities and exchange commission logo
September 12, 2023
Yuantong Wang
Chief Executive Officer
Huaizhong Health Group, Inc.
Tianan Technology Park
13/F Headquarters Center Building 16
555 Panyu North Ave, Panyu District
Guangzhou City, China
Re:Huaizhong Health Group, Inc.
Form 10-K for the Fiscal Year ended October 31, 2022
Filed March 27, 2023
File No. 000-55369
Dear Yuantong Wang:
We issued comments on the above captioned filing on April 12, 2023, and June 2,
2023. On August 22, 2023, we issued a follow-up letter informing you that those comments
remained outstanding and unresolved, and absent a substantive response, we would act consistent
with our obligations under the federal securities laws.
As you have not provided a substantive response, we are terminating our review and will
take further steps as we deem appropriate. These steps include releasing publicly, through the
agency s EDGAR system, all correspondence, including this letter, relating to the review of your
filing, consistent with the staff s decision to publicly release comment and response letters
relating to disclosure filings it has reviewed.
Please contact Robert Babula, Staff Accountant at (202) 551-3339, or Gus Rodriguez at
(202) 551-3752 with any questions.
Sincerely,
Division of Corporation Finance
Office of Energy & Transportation